Things certainly turned around overnight with the funding...

Things certainly turned around overnight with the funding announced today. Looking at the Coviu pricing structure they might wish to pay a monthly prescription fee per customer instead of $5-10 per use as RAP suggested at the beginning of the talk. IMO it is to RAP’s interest to postpone the agreement until government funding available and interest peaks which is right now.

It seems TK’s post today implied RAP should at least play some part of the game in the coming months, it may or may not relate to the Coviu deal, but I rather wait 2 more days than seeing a low price deal tomorrow morning. Pretty sure technical issues are all done it’s only up to the dotted line signature....

All IMO no investment advice here.